Baker A - Search Results

1

Design and rationale of the COVID vaccine-associated myocarditis/pericarditis (CAMP) study.

Truong DT, Harty BJ, Bainton J, Baker A, Bradford TT, Cai B, Coleman J, de Luise C, Dionne A, Friedman K, Gayed J, Graham E, Jone PN, Lanes S, Pearson GD, Portman MA, Powell AJ, Russell MW, Sabati AA, Taylor MD, Wheaton O, Newburger JW; CAMP Study Investigators (Supplement 1). Truong DT, et al. Among authors: baker a. Am Heart J. 2024 Nov 26;281:32-42. doi: 10.1016/j.ahj.2024.11.008. Online ahead of print. Am Heart J. 2024. PMID: 39608555

2

Audiologic profiles of children with Kawasaki disease.

Sundel RP, Cleveland SS, Beiser AS, Newburger JW, McGill T, Baker AL, Koren G, Novak RE, Harris JP, Burns JC. Sundel RP, et al. Among authors: baker al. Am J Otol. 1992 Nov;13(6):512-5. Am J Otol. 1992. PMID: 1280407

3

Gamma-globulin treatment of acute myocarditis in the pediatric population.

Drucker NA, Colan SD, Lewis AB, Beiser AS, Wessel DL, Takahashi M, Baker AL, Perez-Atayde AR, Newburger JW. Drucker NA, et al. Among authors: baker al. Circulation. 1994 Jan;89(1):252-7. doi: 10.1161/01.cir.89.1.252. Circulation. 1994. PMID: 8281654

4

Gamma globulin re-treatment in Kawasaki disease.

Sundel RP, Burns JC, Baker A, Beiser AS, Newburger JW. Sundel RP, et al. Among authors: baker a. J Pediatr. 1993 Oct;123(4):657-9. doi: 10.1016/s0022-3476(05)80972-2. J Pediatr. 1993. PMID: 8410524

5

Effects of nutritional counseling on lipoprotein levels in a pediatric lipid clinic.

Mietus-Snyder M, Baker AL, Neufeld EJ, Roberts C, Dermarkarian S, Beiser AS, Newburger JW. Mietus-Snyder M, et al. Among authors: baker al. Am J Dis Child. 1993 Apr;147(4):378-81. doi: 10.1001/archpedi.1993.02160280028012. Am J Dis Child. 1993. PMID: 8456791

6

Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids.

Wright DA, Newburger JW, Baker A, Sundel RP. Wright DA, et al. Among authors: baker a. J Pediatr. 1996 Jan;128(1):146-9. doi: 10.1016/s0022-3476(96)70447-x. J Pediatr. 1996. PMID: 8551407 Clinical Trial.

7

Analytical performance and clinical utility of a direct LDL-cholesterol assay in a hyperlipidemic pediatric population.

Harris N, Neufeld EJ, Newburger JW, Ticho B, Baker A, Ginsburg GS, Rimm E, Rifai N. Harris N, et al. Among authors: baker a. Clin Chem. 1996 Aug;42(8 Pt 1):1182-8. Clin Chem. 1996. PMID: 8697574

8

Passive cigarette smoking and reduced HDL cholesterol levels in children with high-risk lipid profiles.

Neufeld EJ, Mietus-Snyder M, Beiser AS, Baker AL, Newburger JW. Neufeld EJ, et al. Among authors: baker al. Circulation. 1997 Sep 2;96(5):1403-7. doi: 10.1161/01.cir.96.5.1403. Circulation. 1997. PMID: 9315524

9

A predictive instrument for coronary artery aneurysms in Kawasaki disease. US Multicenter Kawasaki Disease Study Group.

Beiser AS, Takahashi M, Baker AL, Sundel RP, Newburger JW. Beiser AS, et al. Among authors: baker al. Am J Cardiol. 1998 May 1;81(9):1116-20. doi: 10.1016/s0002-9149(98)00116-7. Am J Cardiol. 1998. PMID: 9605052

10

Utility of direct measurement of low-density lipoprotein cholesterol in dyslipidemic pediatric patients.

Ticho BS, Neufeld EJ, Newburger JW, Harris N, Baker A, Rifai N. Ticho BS, et al. Among authors: baker a. Arch Pediatr Adolesc Med. 1998 Aug;152(8):787-91. doi: 10.1001/archpedi.152.8.787. Arch Pediatr Adolesc Med. 1998. PMID: 9701139

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,642 results

Search Page

Filters